UNICHEMLAB

Unichem Laboratories Limited

Unichem Laboratories Limited (UNICHEMLAB) financial statements and selected valuation metrics through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

unichemlabs.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹510.55
Market cap
3,594 Cr
Stock P/E
11.8
P/B
1.32
Dividend yield
0.0%
ROE (FY26)
9.3%
ROCE (FY26)
10.2%
Operating margin (FY26)
2.7%
Debt / equity (FY26)
0.17
OCF / EBITDA (FY26)
2.0%
OCF / EBITDA (3Y)
2.4%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Unichem Laboratories makes and sells generic pharmaceutical formulations and active pharmaceutical ingredients (APIs), mostly to customers outside India, with the USA its largest market.

Company snapshot

67thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Debt-to-equity of 0.17x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Only 2% of operating profit came in as cash over the last three years — much of it is tied up in unpaid bills or stock.

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales416 Cr434 Cr432 Cr446 Cr462 Cr533 Cr587 Cr527 Cr579 Cr521 Cr575 Cr633 Cr
Operating expenses (approx.)407 Cr396 Cr406 Cr403 Cr405 Cr448 Cr503 Cr504 Cr513 Cr476 Cr527 Cr563 Cr
EBITDA9 Cr38 Cr25 Cr43 Cr58 Cr86 Cr84 Cr22 Cr66 Cr45 Cr48 Cr70 Cr
OPM %2.1%8.8%5.9%9.7%12.4%16.0%14.3%4.3%11.4%8.6%8.3%11.1%
Other income6 Cr11 Cr6 Cr4 Cr9 Cr14 Cr9 Cr7 Cr21 Cr12 Cr23 Cr16 Cr
Interest7 Cr6 Cr5 Cr4 Cr5 Cr7 Cr5 Cr7 Cr8 Cr7 Cr9 Cr7 Cr
Depreciation29 Cr28 Cr27 Cr28 Cr29 Cr31 Cr30 Cr32 Cr31 Cr31 Cr31 Cr30 Cr
Profit before tax-22 Cr84 Cr-126 Cr15 Cr33 Cr62 Cr58 Cr-9 Cr-11 Cr293 Cr19 Cr49 Cr
Tax %-11.9%-0.0%-2.7%38.3%7.6%6.5%8.4%-16.1%-9.9%9.9%41.9%15.4%
Net profit-24 Cr84 Cr-129 Cr9 Cr30 Cr58 Cr53 Cr-10 Cr-12 Cr264 Cr11 Cr41 Cr
EPS (₹)₹-3.48₹11.93₹-18.37₹1.31₹4.34₹8.22₹7.52₹-1.49₹-1.69₹37.54₹1.55₹6.61

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales699 Cr818 Cr1,180 Cr1,211 Cr1,235 Cr1,270 Cr1,343 Cr1,705 Cr2,111 Cr2,202 CrSign in free for the trailing twelve months
Operating expenses (approx.)740 Cr950 Cr1,264 Cr1,261 Cr1,144 Cr1,197 Cr1,389 Cr1,605 Cr1,846 Cr2,018 CrSign in free for the trailing twelve months
EBITDA-41 Cr-132 Cr-83 Cr-51 Cr91 Cr73 Cr-46 Cr100 Cr265 Cr184 CrSign in free for the trailing twelve months
OPM %-5.9%-16.1%-7.1%-4.2%7.4%5.7%-3.4%5.9%12.5%8.4%Sign in free for the trailing twelve months
Other income6 Cr61 Cr98 Cr91 Cr50 Cr48 Cr39 Cr32 Cr35 Cr63 CrSign in free for the trailing twelve months
Interest3 Cr8 Cr8 Cr8 Cr5 Cr6 Cr17 Cr23 Cr21 Cr32 CrSign in free for the trailing twelve months
Depreciation44 Cr51 Cr67 Cr82 Cr84 Cr91 Cr113 Cr113 Cr125 Cr125 CrSign in free for the trailing twelve months
Profit before tax-83 Cr3,241 Cr-57 Cr-48 Cr51 Cr22 Cr-176 Cr-62 Cr155 Cr292 CrSign in free for the trailing twelve months
Tax %14.4%21.5%58.6%-24.8%33.3%-50.5%-14.7%-14.3%11.0%13.5%Sign in free for the trailing twelve months
Net profit109 Cr2,545 Cr-24 Cr-60 Cr34 Cr33 Cr-202 Cr-70 Cr138 Cr253 CrSign in free for the trailing twelve months
EPS (₹)₹11.96₹280.60₹-3.38₹-8.55₹4.88₹4.70₹-28.72₹-10.01₹19.53₹35.91Sign in free for the trailing twelve months
Dividend payout %————83.5%85.8%——0.2%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital18 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr14 Cr
Reserves1,045 Cr2,666 Cr2,606 Cr2,517 Cr2,543 Cr2,604 Cr2,421 Cr2,348 Cr2,437 Cr2,703 Cr
Borrowings98 Cr151 Cr200 Cr184 Cr101 Cr330 Cr297 Cr219 Cr430 Cr469 Cr
Other liabilities365 Cr358 Cr330 Cr429 Cr468 Cr370 Cr460 Cr588 Cr689 Cr551 Cr
Total liabilities1,527 Cr3,189 Cr3,150 Cr3,145 Cr3,126 Cr3,319 Cr3,193 Cr3,169 Cr3,569 Cr3,737 Cr
Fixed assets (net)484 Cr572 Cr804 Cr865 Cr879 Cr988 Cr1,255 Cr1,194 Cr1,279 Cr1,204 Cr
CWIP250 Cr238 Cr92 Cr330 Cr567 Cr494 Cr147 Cr123 Cr31 Cr100 Cr
Investments14 Cr901 Cr930 Cr553 Cr396 Cr264 Cr2 Cr1 Cr0.02 Cr0.02 Cr
Loans & advances——0.06 Cr0.04 Cr0.04 Cr0.05 Cr0.06 Cr0.04 Cr0.06 Cr0.06 Cr
Inventories282 Cr273 Cr339 Cr397 Cr538 Cr600 Cr625 Cr705 Cr989 Cr975 Cr
Trade receivables315 Cr272 Cr436 Cr390 Cr250 Cr495 Cr589 Cr610 Cr779 Cr829 Cr
Cash & bank11 Cr666 Cr197 Cr226 Cr77 Cr109 Cr184 Cr151 Cr90 Cr289 Cr
Other assets171 Cr266 Cr351 Cr383 Cr418 Cr368 Cr391 Cr385 Cr402 Cr340 Cr
Total assets1,527 Cr3,189 Cr3,150 Cr3,145 Cr3,126 Cr3,319 Cr3,193 Cr3,169 Cr3,569 Cr3,737 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity68 Cr-112 Cr-328 Cr20 Cr33 Cr-260 Cr-85 Cr17 Cr-7 Cr4 Cr
Cash from investing-128 Cr1,649 Cr-286 Cr-41 Cr-74 Cr100 Cr203 Cr50 Cr-241 Cr192 Cr
Cash from financing59 Cr-881 Cr-2 Cr-62 Cr-121 Cr191 Cr-81 Cr-106 Cr184 Cr2 Cr
Net cash flow-0.46 Cr655 Cr-616 Cr-84 Cr-162 Cr32 Cr38 Cr-33 Cr-65 Cr200 Cr
Free cash flow (OCF − Capex)-82 Cr-272 Cr-522 Cr-366 Cr-255 Cr-387 Cr-129 Cr-6 Cr-144 Cr-119 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %-6.8%114.8%-1.8%-1.5%2.1%1.0%-5.8%-1.5%6.1%10.2%
ROE %10.2%95.0%-0.9%-2.4%1.3%1.3%-8.3%-3.0%5.6%9.3%
Debtor days16412113511874142160131134137
Inventory days391256258343420479428346405462
Days payable292212169217164146199147165169
Cash conversion cycle263165224244330475388330375430
OCF / EBITDA %————36.3%-356.6%—16.7%-2.7%2.0%
OCF / EBITDA % (3 years)—————-182.8%-263.3%n.m.-23.6%2.4%
Debt / equity0.090.060.080.070.040.130.120.090.180.17
Current ratio1.915.034.052.982.722.982.482.392.052.48
Net debt / EBITDA————0.253.04—0.681.290.97